Ace Pharmaceuticals welcomes Dirk Groen as new CEO

New growth phase

Ace Pharmaceuticals has grown tremendously in the past five years under the leadership of Jan Verwaal and Jan Willem Popma. Jan Verwaal: 'In light of our international growth ambitions, we have invested heavily in the production facilities. We have grown into a respected partner in the pharmaceutical industry with a turnover of 50 million euros and more than 200 employees.' Jan Willem Popma: 'As a result, Ace has therefore entered a new development stage. Dirk is the ideal person to shape this new phase and further expand Ace's position as an independent Dutch niche medication specialist in the Netherlands and Europe.'

The right medication available for everyone

Dirk has over 30 years of experience in managing larger organizations in the pharmaceutical industry both in The Netherlands and abroad. The former General Manager at Viatris held various high-level positions in the international pharmaceutical industry.

Dirk Groen: 'Ace is a wonderful company with a unique and socially relevant role in the Netherlands; we manufacture and keep medicines available that would otherwise disappear from the market. With this approach we ensure that even the smallest patient groups have access to the medication they desperately need. With the knowledge, techniques and facilities that we have in-house, we can act widely to prevent and solve medicine shortages, also internationally. I look forward to taking Ace to the next stage in its development and further expanding our position as a niche medicine specialist.”